1. Home
  2. VALN vs WVE Comparison

VALN vs WVE Comparison

Compare VALN & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALN
  • WVE
  • Stock Information
  • Founded
  • VALN 2012
  • WVE 2012
  • Country
  • VALN France
  • WVE Singapore
  • Employees
  • VALN N/A
  • WVE N/A
  • Industry
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • VALN Health Care
  • WVE Health Care
  • Exchange
  • VALN Nasdaq
  • WVE Nasdaq
  • Market Cap
  • VALN 777.9M
  • WVE 915.6M
  • IPO Year
  • VALN 2021
  • WVE 2015
  • Fundamental
  • Price
  • VALN $10.70
  • WVE $7.17
  • Analyst Decision
  • VALN Strong Buy
  • WVE Strong Buy
  • Analyst Count
  • VALN 4
  • WVE 16
  • Target Price
  • VALN $15.75
  • WVE $20.19
  • AVG Volume (30 Days)
  • VALN 78.1K
  • WVE 1.8M
  • Earning Date
  • VALN 11-06-2025
  • WVE 11-11-2025
  • Dividend Yield
  • VALN N/A
  • WVE N/A
  • EPS Growth
  • VALN N/A
  • WVE N/A
  • EPS
  • VALN N/A
  • WVE N/A
  • Revenue
  • VALN $230,566,060.00
  • WVE $93,946,000.00
  • Revenue This Year
  • VALN $15.69
  • WVE N/A
  • Revenue Next Year
  • VALN $22.15
  • WVE $6.85
  • P/E Ratio
  • VALN N/A
  • WVE N/A
  • Revenue Growth
  • VALN 25.47
  • WVE N/A
  • 52 Week Low
  • VALN $3.62
  • WVE $5.28
  • 52 Week High
  • VALN $12.25
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • VALN 55.15
  • WVE 42.05
  • Support Level
  • VALN $9.70
  • WVE $6.91
  • Resistance Level
  • VALN $12.23
  • WVE $7.24
  • Average True Range (ATR)
  • VALN 0.44
  • WVE 0.31
  • MACD
  • VALN 0.05
  • WVE 0.06
  • Stochastic Oscillator
  • VALN 39.92
  • WVE 63.12

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: